Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6342)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol 2015; 21(18): 5524-5531 [PMID: 25987775 DOI: 10.3748/wjg.v21.i18.5524] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i18/5524.htm |
| Number | Citing Articles |
| 1 |
Mindie H Nguyen, Hwai-I Yang, An Le, Linda Henry, Nghia Nguyen, Mei-Hsuan Lee, Jian Zhang, Christopher Wong, Clifford Wong, Huy Trinh. Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study. The Journal of Infectious Diseases 2019; 219(1): 10 doi: 10.1093/infdis/jiy391
|
| 2 |
P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler, T. Berg. Review article: long‐term safety of nucleoside and nucleotide analogues in HBV‐monoinfected patients. Alimentary Pharmacology & Therapeutics 2016; 44(1): 16 doi: 10.1111/apt.13659
|
| 3 |
Calvin Q. Pan, Zhongping Duan, Erhei Dai, Shuqin Zhang, Guorong Han, Yuming Wang, Huaihong Zhang, Huaibin Zou, Baoshen Zhu, Wenjing Zhao, Hongxiu Jiang. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. New England Journal of Medicine 2016; 374(24): 2324 doi: 10.1056/NEJMoa1508660
|
| 4 |
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
|
| 5 |
Ming Wang, Qian Bian, Yunxia Zhu, Qiumei Pang, Lingzhi Chang, Ran Li, Benjamin C. Tiongson, Hua Zhang, Calvin Q. Pan. Real‐world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Alimentary Pharmacology & Therapeutics 2019; 49(2): 211 doi: 10.1111/apt.15064
|
| 6 |
Manoj Kumar, Zaigham Abbas, Milad Azami, Maria Belopolskaya, A. K. Dokmeci, Hasmik Ghazinyan, Jidong Jia, Ankur Jindal, Han Chu Lee, Wei Lei, Seng Gee Lim, Chun-Jen Liu, Qiang Li, Mamun Al Mahtab, David H. Muljono, Madunil Anuk Niriella, Masao Omata, Diana A. Payawal, Shiv K. Sarin, Olivier Ségéral, Tawesak Tanwandee, Nirupma Trehanpati, Kumar Visvanathan, Jin Mo Yang, Man‑Fung Yuen, Yingjie Zheng, Y. H. Zhou. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatology International 2022; 16(2): 211 doi: 10.1007/s12072-021-10285-5
|
| 7 |
M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. An expert consensus for the management of chronic hepatitis B in Asian Americans. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1181 doi: 10.1111/apt.14577
|
| 8 |
Jiaming Zhu, Saro Khemichian, Dat Nghiem, Shi-Rong Zhang, Joyce Limurti, Takeshi Saito, Tse-Ling Fong. Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern California. Journal of Clinical Gastroenterology 2016; 50(7): 602 doi: 10.1097/MCG.0000000000000486
|
| 9 |
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad Hospital. Jundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
|
| 10 |
Jae Young Choe, Jae Sung Ko, Byung-Ho Choe, Jung Eun Kim, Ben Kang, Kyung Jae Lee, Hye Ran Yang. Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B. Journal of Korean Medical Science 2018; 33(2) doi: 10.3346/jkms.2018.33.e11
|
| 11 |
Kazumoto Murata, Masashi Mizokami. Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2023; 38(5): 683 doi: 10.1111/jgh.16178
|
| 12 |
Calvin Q. Pan, Ming‐Hui Li, Wei Yi, Lu Zhang, Yao Lu, Hong‐Xiao Hao, Gang Wan, Wei‐Hua Cao, Xing‐Yue Wang, Chong‐Ping Ran, Ge Shen, Shu‐Ling Wu, Min Chang, Yuan‐Jiao Gao, Yao Xie. Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens. Liver International 2021; 41(7): 1498 doi: 10.1111/liv.14801
|
| 13 |
Sheila F. Lumley, Marion Delphin, Jolynne F. Mokaya, Cedric C.S. Tan, Emily Martyn, Motswedi Anderson, Ka Chun Li, Elizabeth Waddilove, Gloria Sukali, Louise O. Downs, Khadija Said, Dorcas Okanda, Cori Campbell, Eli Harriss, Yusuke Shimakawa, Philippa C. Matthews. A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir. Journal of Clinical Virology 2024; 174: 105711 doi: 10.1016/j.jcv.2024.105711
|